From the Department of Pharmacokinetics, Dynamics, and Drug Metabolism, Pfizer Global Research and Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340.
J Biol Chem. 2010 Oct 8;285(41):31185-92. doi: 10.1074/jbc.M110.107805. Epub 2010 Aug 11.
In the present study MRP2/ABCC2 and BSEP/ABCB11 expression were investigated in sandwich cultured (SC) human and rat hepatocytes exposed to the proinflammatory cytokines. The investigation was also done in lipopolysaccharide (LPS)-treated rats. In SC human hepatocytes, both absolute protein and mRNA levels of MRP2/ABCC2 were significantly down-regulated by TNF-α, IL-6, or IL-1β. In contrast to mRNA decrease, which was observed for BSEP/ABCB11, the protein amount was significantly increased by IL-6 or IL-1β. A discrepancy between the change in BSEP/ABCB11 mRNA and protein levels was encountered in SC human hepatocytes treated with proinflammatory cytokines. In SC rat hepatocytes, Mrp2/Abcc2 mRNA was down-regulated by TNF-α and IL-6, whereas the protein level was decreased by all three cytokines. Down-regulations of both Bsep/Abcb11 mRNA and protein levels were found in SC rat hepatocytes exposed to TNF-α or IL-1β. Administration of LPS triggered the release of the proinflammatory cytokines and caused the decrease of Mrp2/Abcc2 and Bsep/Abcb11 protein in liver at 24 h post-treatment; however, the Mrp2 and Bsep protein levels rebounded at 48 h post-LPS treatment. In total, our results indicate that proinflammatory cytokines regulate the expression of MRP2/Mrp2 and BSEP/Bsep and for the first time demonstrate the differential effects on BSEP/Bsep expression between SC human and rat hepatocytes. Furthermore, the agreement between transporter regulation in vitro in SC rat hepatocytes and in vivo in LPS-treated rats during the acute response phase demonstrates the utility of in vitro SC hepatocyte models for predicting in vivo effects.
在本研究中,研究人员调查了在炎性细胞因子作用下,三明治培养(SC)的人源和鼠源肝细胞中 MRP2/ABCC2 和 BSEP/ABCB11 的表达情况。此外,研究人员还在脂多糖(LPS)处理的大鼠中进行了同样的调查。在 SC 人源肝细胞中,TNF-α、IL-6 或 IL-1β 可显著下调 MRP2/ABCC2 的蛋白和 mRNA 水平。与 BSEP/ABCB11 的 mRNA 减少相反,IL-6 或 IL-1β 可显著增加其蛋白量。在 SC 人源肝细胞中,炎性细胞因子可导致 BSEP/ABCB11 的 mRNA 和蛋白水平改变出现差异。在 SC 鼠源肝细胞中,TNF-α 和 IL-6 可下调 Mrp2/Abcc2 的 mRNA 水平,而三种细胞因子均可降低其蛋白水平。TNF-α 或 IL-1β 可降低 SC 鼠源肝细胞中 Bsep/Abcb11 的 mRNA 和蛋白水平。LPS 处理可触发炎性细胞因子的释放,并导致 24 小时后肝内 Mrp2/Abcc2 和 Bsep/Abcb11 蛋白减少;然而,在 LPS 处理 48 小时后,Mrp2 和 Bsep 蛋白水平出现反弹。综上所述,研究结果表明,炎性细胞因子可调节 MRP2/Mrp2 和 BSEP/Bsep 的表达,并首次证明了 SC 人源和鼠源肝细胞中 BSEP/Bsep 表达的差异效应。此外,在急性反应阶段,SC 鼠源肝细胞中的体外转运体调节作用与 LPS 处理大鼠中的体内作用一致,这证明了体外 SC 肝细胞模型在预测体内作用方面的实用性。